MT
Mansi Tapan Sanghvi
About Mansi Tapan Sanghvi
Data last updated:
Mansi Tapan Sanghvi is a Director at U S Pharma (India) Private Limited (since 2020), Director at Oceanic Laboratories Private Limited (since 2021) and Director at U S Medi Science (India) Private Limited (since 2026), and holds 1 more current directorship. The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹95.66 Cr; the largest is U S Pharma (India) Private Limited at ₹89.26 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 U S Pharma (India) Private Limited U24230MH2003PTC140514 | Director | 30 Sep 2020 | 2003 | ₹89.26 Cr (FY 2025) | Active |
 Oceanic Laboratories Private Limited U24100MH1991PTC061013 | Director | 09 Mar 2021 | 1991 | ₹6.40 Cr (FY 2024) | Active |
| U S Medi Science (India) Private Limited U32509MR2026PTC480015 | Director | 22 Aug 2026 | 2026 | Active | |
| Euro Medicare Laboratories Llp AAM-7820 | Designated Partner | 07 Jun 2018 | 2018 | Active |
Board colleagues of Mansi Tapan Sanghvi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Tapan Haresh Sanghvi | 06564350 | U S Pharma (India) Private Limited , Oceanic Laboratories Private Limited and 2 more | Director |
| Chetan Khantilal Sanghavi | 09074834 | Oceanic Laboratories Private Limited | Director |
| Hareshkumar Pravinchandra Sanghvi | 09096675 | Oceanic Laboratories Private Limited , U S Medi Science (India) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mansi Tapan Sanghvi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mansi Tapan Sanghvi
Mansi Tapan Sanghvi currently holds 4 directorships: U S Pharma (India) Private Limited (Director, since 30 Sep 2020, revenue ₹89.26 Cr (FY 2025)); Oceanic Laboratories Private Limited (Director, since 09 Mar 2021, revenue ₹6.40 Cr (FY 2024)); U S Medi Science (India) Private Limited (Director, since 22 Aug 2026); Euro Medicare Laboratories Llp (Designated Partner, since 07 Jun 2018).
Mansi Tapan Sanghvi was first appointed on 07 Jun 2018 as Designated Partner at Euro Medicare Laboratories Llp. The most recent appointment on record is 22 Aug 2026 at U S Medi Science (India) Private Limited.
The 2 current companies of Mansi Tapan Sanghvi that report revenue have a combined latest revenue of ₹95.66 Cr: U S Pharma (India) Private Limited ₹89.26 Cr (FY 2025); Oceanic Laboratories Private Limited ₹6.40 Cr (FY 2024).
The current boards of Mansi Tapan Sanghvi's companies include Tapan Haresh Sanghvi (U S Pharma (India) Private Limited), Chetan Khantilal Sanghavi (Oceanic Laboratories Private Limited), Hareshkumar Pravinchandra Sanghvi (Oceanic Laboratories Private Limited).